Major opioid maker to pay for overdose-antidote development
NATIONAL. (ASSOCIATED PRESS) – A company whose prescription opioid marketing practices are being blamed for sparking a nationwide overdose and addiction crisis says it’s helping fund an effort to make a lower-cost overdose antidote.
OxyContin maker Purdue Pharma announced on Wednesday that it’s making a $3.4 million grant to Harm Reduction Therapeutics, a Pittsburgh-based nonprofit, to help develop a low-cost naloxone (nuh-LAHX’-ohn) nasal spray.
First responders, drug users and others have taken to carrying naloxone to reverse overdoses. But the price of the drug has been a problem for state and local governments.
Harm Reduction Therapeutics says it is trying to get its version to the market within two years.
The announcement from Stamford, Connecticut-based Purdue days after the number of lawsuits against the drug industry under one federal judge’s watch topped 1,000.
(Copyright 2018 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
9/5/2018 12:16:29 PM (GMT -4:00)